The association between working alliance and clinical and functional outcome in a cohort of 400 patients with first-episode psychosis: A cross-sectional study

Journal of Clinical Psychiatry

Volumn 76, Issue 1, 2015, Pages e83-e90

  Melau, Marianne ^a   Harder, Susanne ^c   Jeppesen, Pia ^a   Hjorthøj, Carsten ^a   Jepsen, Jens R M ^a,b,d   Thorup, Anne ^a   Nordentoft, Merete ^a  

^a Mental Health Centre Copenhagen   (Denmark)

^b Center for Neuropsychiatric Schizophrenia Research   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d University Psychiatric Center Glostrup   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; ASSESSMENT OF HUMANS; BRIEF ASSESSMENT OF COGNITION IN SCHIZOPHRENIA; BRIEF PSYCHOTIC DISORDER; CASE MANAGER; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DELUSIONAL DISORDER; EARLY INTERVENTION; FEMALE; FUNCTIONAL STATUS; GENDER; GENERAL SELF EFFICACY; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; ICD-10; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MENTAL DISEASE ASSESSMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SELF CONCEPT; SOCIAL INTERACTION; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; VARIANCE; WORKING ALLIANCE; WORKING ALLIANCE INVENTORY; CASE MANAGEMENT; DENMARK; HUMAN RELATION; PSYCHOLOGY; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; YOUNG ADULT;

ADULT; CASE MANAGEMENT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DENMARK; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PROFESSIONAL-PATIENT RELATIONS; PSYCHOTIC DISORDERS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84925353005     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.13m08814     Document Type: Article

References (47)

1. Horvath AO, Symonds BD. Relation between working alliance and outcome in psychotherapy: a meta-analysis. J Couns Psychol. 1991;38(2):139-149.
2. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol. 2000;68(3):438-450.
3. Bordin ES. The generalizability of the psychoanalytic concept of the working alliance. Psychother Theory Res Pract. 1979;16(3):252-260.
4. Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;36(2):223-233.
5. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr Bull. 1997;23(4):637-651.
6. Frank AF, Gunderson JG. The role of the therapeutic alliance in the treatment of schizophrenia: relationship to course and outcome. Arch Gen Psychiatry. 1990;47(3):228-236.
7. Svensson B, Hansson L. Relationships among patient and therapist ratings of therapeutic alliance and patient assessments of therapeutic process: a study of cognitive therapy with long-term mentally ill patients. J Nerv Ment Dis. 1999;187(9):579-585.
8. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002;63(10):892-909.
9. Montreuil TC, Cassidy CM, Rabinovitch M, et al. Case manager- and patient-rated alliance as a predictor of medication adherence in first-episode psychosis. J Clin Psychopharmacol. 2012;32(4):465-469.
10. Misdrahi D, Petit M, Blanc O, et al. The influence of therapeutic alliance and insight on medication adherence in schizophrenia. Nord J Psychiatry. 2012;66(1):49-54.
11. Howgego IM, Yellowlees P, Owen C, et al. The therapeutic alliance: the key to effective patient outcome? a descriptive review of the evidence in community mental health case management. Aust N Z J Psychiatry. 2003;37(2):169-183.
12. Klinkenberg WD, Calsyn RJ, Morse GA. The helping alliance in case management for homeless persons with severe mental illness. Community Ment Health J. 1998;34(6):569-578.
13. Calsyn RJ, Klinkenberg WD, Morse GA, et al. Predictors of the working alliance in assertive community treatment. Community Ment Health J. 2006;42(2):161-175.
14. Calsyn RJ, Morse GA, Allen G. Predicting the helping alliance with people with a psychiatric disability. Psychiatr Rehabil J. 1999;22(3):283-287.
15. Cunningham J, Calsyn RJ, Burger GK, et al. Client outcomes and the working alliance in the client-case manager relationship: a causal analysis. Care Manag J; 2007;8(3):106-112.
16. Bourdeau G, Théroux L, Lecomte T. Predictors of therapeutic alliance in early psychosis. Early Interv Psychiatry. 2009;3(4):300-303.
17. Petersen L, Jeppesen P, Thorup A, et al. A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness. BMJ. 2005;331(7517):602-605.
18. Bertolote J, McGorry P. Early intervention and recovery for young people with early psychosis: consensus statement. Br J Psychiatry suppl. 2005;187(48):s116-s119.
19. McGorry PD, Edwards J, Mihalopoulos C, et al. EPPIC: an evolving system of early detection and optimal management. Schizophr Bull. 1996;22(2):305-326.
20. Craig TK, Garety P, Power P, et al. The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ. 2004;329(7474):1067.
21. Marshall M, Lockwood A, Lewis S, et al. Essential elements of an early intervention service for psychosis: the opinions of expert clinicians. BMC Psychiatry. 2004;4:17.
22. Bandura A, Locke EA. Negative self-efficacy and goal effects revisited. J Appl Psychol. 2003;88(1):87-99.
23. Bandura A. On the functional properties of perceived self-efficacy revisited. J Manage. 2012;38(1):9-44.
24. Melau M, Bertelsen M, Jeppesen P, et al. A randomised clinical trial of the effect of five-years versus two-years specialised assertive intervention for first episode psychosis - the Opus II Trial. Schizophr Res. 2010;117(2-3):526.
25. Stein LI, Santos AB. Assertive Community Treatment of Persons With Severe Mental Illness. New York, NY; London, UK: W W Norton & Company; 1998.
26. McFarlane WR, Dixon L, Lukens E, et al. Family psychoeducation and schizophrenia: a review of the literature. J Marital Fam Ther. 2003;29(2):223-245.
27. Anderson CM, Reiss D, Hogartry GE. Schizophrenia and the Family: A Practitioner's Guide to Psychoeducation and Management. New York, NY: The Guilford Press; 1986.
28. McFarlane WR, Lukens E, Link B, et al. Multiple-family groups and psychoeducation in the treatment of schizophrenia. Arch Gen Psychiatry. 1995;52(8):679-687.
29. Liberman RP, Mueser KT, Wallace CJ. Social skills training for schizophrenic individuals at risk for relapse. Am J Psychiatry. 1986;143(4):523-526.
30. Wing JK, Babor T, Brugha T, et al. Schedules for Clinical Assessment in Neuropsychiatry. SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry. 1990;47(6):589-593.
31. Horvath AO, Greenberg LS. The Working Alliance: Theory, Research, and Practice. New York, NY: Wiley; 1994.
32. Tracey TJ, Kokotovic AM. Factor structure of the Working Alliance Inventory. Psychol Assess. 1989;1(3):207-210.
33. Bordin ES. Theory and Research on the Working Alliance: New Directions. The Working Alliance: Theory, Research, and Practice. New York, NY: Wiley; 1994:13-37.
34. Andreasen NC, Olsen S. Negative v positive schizophrenia: definition and validation. Arch Gen Psychiatry. 1982;39(7):789-794.
35. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch Gen Psychiatry. 1982;39(7):784-788.
36. Arndt S, Andreasen NC, Flaum M, et al. A longitudinal study of symptom dimensions in schizophrenia: prediction and patterns of change. Arch Gen Psychiatry. 1995;52(5):352-360.
37. Endicott J, Spitzer RL, Fleiss JL, et al. The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33(6):766-771.
38. Luszczynska A, Scholz U, Schwarzer R. The General Self-Efficacy Scale: multicultural validation studies. J Psychol. 2005;139(5):439-457.
39. Keefe RSE, Goldberg TE, Harvey PD, et al. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2-3):283-297.
40. Keefe RSE, Harvey PD, Goldberg TE, et al. Norms and standardization of the Brief Assessment of Cognition in Schizophrenia (BACS). Schizophr Res. 2008;102(1-3):108-115.
41. Malla A, Payne J. First-episode psychosis: psychopathology, quality of life, and functional outcome. Schizophr Bull. 2005;31(3):650-671.
42. Ventura J, Nuechterlein KH, Subotnik KL, et al. Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia. Schizophr Res. 2004;69(2-3):343-352.
43. Bandura A, Caprara GV, Barbaranelli C, et al. Role of affective self-regulatory efficacy in diverse spheres of psychosocial functioning. Child Dev. 2003;74(3):769-782.
44. Bandura A. Regulation of cognitive-processes through perceived self-efficacy. Dev Psychol. 1989;25(5):729-735.
45. Thorup A, Petersen L, Jeppesen P, et al. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. J Nerv Ment Dis. 2007;195(5):396-405.
46. Thorup A, Petersen L, Jeppesen P, et al. The opus trial: gender differences in a sample of 547 first-episode psychotic patients. Schizophr Bull. 2005;31(2):505.
47. Koester A, Lajer M, Lindhardt A, et al. The Danish national schizophrenia project: response to clinical treatment according to gender in first episode psychosis. Eur Psychiatry. 2008;23:S124-S125.